A
AstraZeneca is a global, science-led biopharmaceutical company formed in 1999 that discovers, develops and commercialises prescription medicines used by millions of patients worldwide.
6 open jobs
Mallinckrodt Pharmaceuticals
Pharmaceutical company with 150+ years of history in specialty medicines, generics and medical imaging; after a 2025 combination with Endo, its businesses operate as Keenova Therapeutics and Par Health.
Mallinckrodt Pharmaceuticals is a pharmaceutical company with a history of more than 150 years, rooted in pharmaceutical manufacturing. It developed, manufactured, marketed and distributed specialty medicines, generic drugs and medical imaging products. In 2025 the company combined with Endo, forming a larger, diversified pharmaceuticals business; the combined operations now run as two separate companies.
Keenova Therapeutics is the rebranded specialty therapeutics business, focusing on immunology, urology, hepatology, ophthalmology, orthopedics and critical care. Par Health is the separated generics and sterile injectables business, developing generic pharmaceuticals, sterile injectables and active pharmaceutical ingredients (API). Mallinckrodt's website now directs visitors to the two entities, which have distinct missions and identities.
The technical domains spanned by the former organisation include pharmaceutical manufacturing, specialty therapeutics, generic drug development, sterile injectables, active pharmaceutical ingredients, medical imaging products and complex pharmaceutical capabilities. Its product portfolio comprised branded specialty medicines, generic drugs and medical imaging products.
Stated cultural signals include a mission of managing complexity and improving lives, and a focus on broadening patient access to medicines.
Open jobs
No open jobs right now.